Audrey E. Dugue
Caen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
Journal: BMC cancer
Published: November 26, 2018
Optimisation of chemotherapy prescription and preparation in an ambulatory unit: Validation of the OPTIMA program.
Journal: European journal of cancer care
Published: July 25, 2018
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study.
Journal: BMC cancer
Published: January 16, 2017
Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: January 05, 2017
BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer.
Journal: Familial cancer
Published: October 27, 2016
Predictive factors of 18F-choline PET/CT positivity in patients with prostate cancer recurrence after radiation therapy: is the impact of PSA nadir underestimated?
Journal: EJNMMI research
Published: September 05, 2016
Sense and sensibility to early combine bevacizumab to radiation treatment of brain metastasis: reply to Lou and Sperduto.
Journal: Annals of translational medicine
Published: May 11, 2016
How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R Software.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 21, 2016
Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Journal: British journal of clinical pharmacology
Published: January 25, 2016
Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
Journal: Nuclear medicine communications
Published: December 08, 2015
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 28, 2015
Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?
Journal: EJNMMI research
Published: August 13, 2015
Last Updated: 09/26/2026